Trajectory of cognitive decline as a predictor of psychosis in early alzheimer disease in the cardiovascular health study

American Journal of Geriatric Psychiatry

Volumn 19, Issue 2, 2011, Pages 160-168

  Emanuel, James E ^a   Lopez, Oscar L ^a   Houck, Patricia R ^a   Becker, James T ^a   Weamer, Elise A ^a   Demichele Sweet, Mary Ann A ^a   Kuller, Lewis ^b   Sweet, Robert A ^a,c  

^a Department of Psychiatry ^*  (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Alzheimer disease; MCI (mild cognitive impairment); psychosis

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E4;

AGED; ALZHEIMER DISEASE; ARTICLE; COGNITION; CONTROLLED STUDY; DIGIT SYMBOL SUBSTITUTION TEST; FEMALE; FOLLOW UP; GENOTYPE; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL TEST; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; NEUROBIOLOGY; PSYCHOSIS;

EID: 79551498241     PISSN: 10647481     EISSN: 15457214     Source Type: Journal    
DOI: 10.1097/JGP.0b013e3181e446c8     Document Type: Article

References (29)

1. Ropacki SA, Jeste DV: Epidemiology of and risk factors for psychosis of Alzheimer's disease: a review of 55 studies published from 1990 to 2003. Am J Psychiatry 2005; 162:2022-2030
2. Kaufer DI, Cummings JL, Christine D, et al: Assessing the impact of neuropsychiatric symptoms in Alzheimer's disease: the Neu-ropsychiatric Inventory Caregiver Distress Scale. J Am Geriatr Soc 1998; 46:210-215
3. Scarmeas N, Brandt J, Albert M, et al: Delusions and hallucinations are associated with worse outcome in Alzheimer disease. Arch Neurol 2005; 62:1601-1608
4. Bacanu SA, Devlin B, Chowdari KV, et al: Heritability of psychosis in Alzheimer disease. Am J Geriatr Psychiatry 2005;13:624-627
5. Sweet RA, Nimgaonkar VL, Devlin B, et al: Increased familial risk of the psychotic phenotype of Alzheimer disease. Neurology 2002; 58:907-911
6. Hollingworth P, Hamshere ML, Holmans PA, et al: Increased familial risk and genomewide significant linkage for Alzheimer's disease with psychosis. Am J Med Genet B Neuropsychiatr Genet 2007; 144B:841-848
7. Sweet RA, Nimgaonkr VL, Devlin B, et al: Psychotic symptoms in Alzheimer disease: evidence for a distinct phenotype. Mol Psychiatry 2003; 8:383-392
8. Weamer EA, Emanuel JE, Varon D, et al: The relationship of excess cognitive impairment in MCI and early Alzheimer's disease to the subsequent emergence of psychosis. Int Psychogeriatr 2009; 21:78-85
9. Paulsen JS, Salmon DP, Thal LJ, et al: Incidence of and risk factors for hallucinations and delusions in patients with probable Alzheimer's disease. Neurology 2000; 54:1965-1971
10. Wilkosz PA, Miyahara S, Lopez OL, et al: Prediction of psychosis onset in Alzheimer disease: the role of cognitive impairment, depressive symptoms, and further evidence for psychosis subtypes. Am J Geriatr Psychiatry 2006; 14:352-356
11. Elias MF, Beiser A, Wolf PA, et al: The preclinical phase of alzheimer disease: a 22-year prospective study of the Framing-ham Cohort. Arch Neurol 2000; 57:808-813
12. Mintun MA, Larossa GN, Sheline YI, et al: [11C]PIB in a non-demented population: potential antecedent marker of Alzheimer disease. Neurology 2006; 67:446-452
13. Lopez OL, Kuller LH, Fitzpatrick A, et al: Evaluation of dementia in the cardiovascular health cognition study. Neuroepidemiology 2003; 22:1-12 (Pubitemid 36131968)
14. Fried LP, Borhani NO, Enright P, et al: The Cardiovascular Health Study: design and rationale. Ann Epidemiol 1991; 1:263-276
15. Tell GS, Fried LP, Hermanson B, et al: Recruitment of adults 65 years and older as participants in the Cardiovascular Health Study. Ann Epidemiol 1993; 3:358-366
16. Teng EL, Chui HC: The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry 1987; 48:314-318
17. Wechsler D: Wechsler Adult Intelligence Scale Manual. New York, Psychological Corporation, 1955
18. Lopez OL, Becker JT, Jagust WJ, et al: Neuropsychological characteristics of mild cognitive impairment subgroups. J Neurol Neu-rosurg Psychiatry 2006; 77:159-165
19. Cummings JL, Mega M, Gray K, et al: The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994; 44:2308-2314
20. Lopez OL, Kuller LH, Becker JT, et al: Incidence of dementia in mild cognitive impairment in the cardiovascular health study cognition study. Arch Neurol 2007; 64:416-420
21. Terry RD, Masliah E, Salmon DP, et al: Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 1991; 30:572-580
22. Grutzendler J, Helmin K, Tsai J, et al: Various dendritic abnormalities are associated with fibrillar amyloid deposits in Alzheimer's disease. Ann N Y Acad Sci 2007; 1097:30-39
23. Walsh DM, Selkoe DJ: A beta oligomers - a decade of discovery. J Neurochem 2007; 101:1172-1184
24. Selkoe DJ: Alzheimer's disease is a synaptic failure. Science 2002; 298:789-791
25. Hsia AY, Masliah E, McConlogue L, et al: Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. Proc Natl Acad Sci USA 1999; 96:3228-3233
26. Naslund J, Haroutunian V, Mohs R, et al: Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. JAMA 2000; 283:1571-1577
27. Sweet RA, Panchalingam K, Pettegrew JW, et al: Psychosis in Alzheimer disease: postmortem magnetic resonance spec-troscopy evidence of excess neuronal and membrane phospho-lipid pathology. Neurobiol Aging 2002; 23:547-553
28. Lewis DA, Sweet RA: Schizophrenia from a neural circuitry perspective: advancing toward rational pharmacological therapies. J Clin Invest 2009; 119:706-716
29. Sweet RA, Hamilton RL, Lopez OL, et al: Psychotic symptoms in Alzheimer's disease are not associated with more severe neuropathologic features. Int Psychogeriatr 2000; 12:547-558